Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 1,006.75
+56.45 (5.94%)
Sep 8, 2026, 12:10 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 150.91 billion as of September 4, 2026. Its market cap has decreased by -10.93% in one year.
Market Cap
150.91B
Enterprise Value
174.42B
Revenue
86.08B
Ranking
n/a
PE Ratio
42.86
Stock Price
1,006.75
ChartMarket Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 150.91B, an increase of 37,003.47%. That is a compound annual growth rate of 25.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 150.91B | -11.35% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 284.30B |
| Eris Lifesciences | 183.14B |
| Cohance Lifesciences | 174.68B |
| Alivus Life Sciences | 167.70B |
| Alembic Pharmaceuticals | 158.86B |
| Sudeep Pharma | 150.14B |
| NATCO Pharma | 148.42B |
| Akums Drugs and Pharmaceuticals | 117.24B |